Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. scores highest on Torque (44) and lowest on Nitro (23). Its PosiPenta is 35.49 out of 100, weaker than most similar companies.
On the Penta Grid this week, Entrada Therapeutics, Inc. is Grid #653 of 837 in the Healthcare sector in United States, and Grid #3,258 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. | 35.49 | 43 | 28 | 23 | 44 | 39 |
| Whitehawk Therapeutics, Inc. | 51.12 | 40 | 38 | 53 | 70 | 54 |
| Yarrow Bioscience Inc | 43.02 | 18 | — | 34 | 88 | 32 |
| PepGen Inc. | 35.04 | 33 | 35 | 38 | 42 | 27 |
| Inogen, Inc. | 54.59 | 40 | 61 | 64 | 61 | 47 |
| Eledon Pharmaceuticals, Inc. | 38.77 | 13 | 42 | 47 | 52 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.10 |
| P/B ratio | 0.73 |
EEarnings
| Trailing EPS | ₹-375.07 |
| Forward EPS | ₹-285.09 |
NNitro
| Price | 413.90 |
| 52-week high | 1558.06 |
| 52-week low | 389.18 |
| Fall from 52-week high | 73.4% |
TTorque
| Return on equity (ROE) | -54.09% |
| Debt-to-equity | 0.21 |
AAnchor
| Beta (price swings) | -0.24 |
| Market cap | ₹1,611 Cr |
| Insider holding | 12.23% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Entrada Therapeutics, Inc.'s PosiPenta score?
Entrada Therapeutics, Inc.'s PosiPenta is 35.49 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Entrada Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Entrada Therapeutics, Inc. is Grid #653 of 837 in the Healthcare sector in United States, and Grid #3,258 of 4,000 in United States.
Which PosiPenta pillar is strongest for Entrada Therapeutics, Inc.?
Torque (durability), with a score of 44 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Entrada Therapeutics, Inc.?
Nitro (momentum), with a score of 23 out of 100: weaker than most similar companies.
Has Entrada Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.95 points, from 32.54 to 35.49.
PositoAI is for research and education only and is not investment advice.